Canada markets closed

BerGenBio ASA (7BG.MU)

Munich - Munich Delayed Price. Currency in EUR
Add to watchlist
0.01120.0000 (0.00%)
At close: 08:06AM CEST
Show:
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
2023-12-31
2022-12-31
2021-12-31
2020-12-31
Total Revenue
354
354
389
774
601
Operating Expenses
Research Development
107,786
107,786
202,403
205,820
185,234
Selling General and Administrative
-
-
-
12,744
21,792
Total Operating Expenses
192,173
192,173
306,024
315,236
261,693
Operating Income or Loss
-191,819
-191,819
-305,635
-314,462
-261,092
Interest Expense
578
578
321
53
32
Income Before Tax
-190,401
-190,401
-302,122
-309,364
-257,029
Income Tax Expense
0
0
0
0
0
Income from Continuing Operations
-190,401
-190,401
-302,122
-309,364
-257,029
Net Income
-190,401
-190,401
-302,122
-309,364
-257,029
Net Income available to common shareholders
-190,401
-190,401
-302,122
-309,364
-257,029
Basic EPS
-0.55
-0.13
-3.41
-3.04
-2.96
Diluted EPS
-0.55
-0.13
-3.41
-3.04
-2.96
Basic Average Shares
804,599
1,431,301
88,636
101,876
86,776
Diluted Average Shares
804,599
1,431,301
88,636
101,876
86,776